Global Atrophic Scars Treatment Market – Industry Trends and Forecast to 2030

Atrophic Scars Treatment Market Analysis and Size

Atrophic scar treatment is referred to as a treatment that is developed for treating atrophic scars. The atrophic scars are created when the skin is not able to redevelop tissue correctly. Atrophic scars, not like hypertrophic and keloid scars, are sunken in appearance because of the healing that goes on below the expected layer of skin. Major factors that are expected to boost the growth of the atrophic scars treatment market in the forecast period are the increase in the prevalence of skin disorders. Furthermore, the rise in the demand for advanced treatment substitutes and product improvements is further anticipated to propel the growth of the atrophic scars treatment market. Moreover, the upsurge in the requirement for age-defying treatment therapies around the world is further estimated to cushion the growth of the atrophic scars treatment market.                         

Data Bridge Market Research analyses that the market, which was USD 3,087.96 million in 2022, would rocket up to USD 11,091.36 million by 2030 and is expected to undergo a CAGR of 4.8% during the forecast period. The Laser dominates the product type segment of the atrophic scars treatment market owing to the rising cases of skin-related issues among the population. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Atrophic Scars Treatment Market Scope and Segmentation

Market Definition

Atrophic scars are a frequent scar that resemble depressions or indentations in the skin and are often caused by the destruction or loss of underlying components like collagen and fat. They may be brought on by certain skin disorders, operations, wounds, or acne. The term "atrophic scars treatment" refers to the range of methods and procedures used to enhance and lessen the visibility of atrophic scars. Treatment aims to stimulate skin regeneration, increase collagen production, and restore the affected area's natural texture and contour.

Atrophic Scars Treatment Market Dynamics

Drivers

• Rising incidences of skin disorders

Atrophic scars can form as a result of infections, psoriasis, eczema, and other skin conditions. A bigger population of people needs treatment for the atrophic scars that emerge from these skin disorders as their frequency rises. Scar management is receiving more attention as awareness of the psychological effects of atrophic scars grows. This stimulates the market's expansion and increases demand for treatments for atrophic scars.

• Growing awareness regarding skin disorders and treatment

People are more likely to look for information about possible treatments due to growing knowledge of skin illnesses and their potential repercussions, including atrophic scarring. Knowledge about skin conditions and the significance of scar therapy is spread thanks to the availability of educational resources, online platforms, and awareness campaigns run by dermatological associations and organizations. More people are actively seeking therapy for their scars due to this awareness. Hence, the growing awareness regarding skin disorders and treatment is driving the market's growth.

• The increasing economy of emerging countries

The population's disposable income rises as emerging nations enjoy economic expansion. People can now set aside a percentage of their salary for aesthetic procedures, such as treating atrophic scars. Modernization of medical institutions and healthcare infrastructure is frequently a result of a more robust economy. This encourages the availability of accessible therapeutic options for atrophic scars. As a result, the market is expected to develop as demand for atrophic scar treatment alternatives rises.

Opportunities

• Rising demand for non-invasive and minimally invasive procedures

The healthcare sector is seeing increased demand for non-invasive and minimally invasive procedures, including scar therapy. These procedures have benefits like shorter recovery times, fewer side effects, and minimal downtime. By creating and promoting less intrusive scar treatment solutions, the market can take advantage of this trend and grow due to increasing patient acceptance.

• Rising medical tourism

Patients from various nations looking for high-quality, high-quality, affordable healthcare services are drawn to medical tourism. The variety of aesthetic and dermatological procedures that medical tourists seek frequently includes scar treatment. For companies that provide scar therapy, it may be a significant source of income. Patients who travel for scar therapy may spend money on  various services, such as consultations, diagnostic procedures, treatments, and follow-up care. This influx of patients broadens the pool of possible clients for companies that offer scar treatment, increasing demand and fuelling market growth.

• Increasing strategic collaborations and partnership

Research institutes, dermatologists, pharmaceutical businesses, and technology developers working together can promote innovation and expand the market. Partnerships can speed up research and development activities, ease the sharing of knowledge and skills, and improve the commercialization of novel treatment choices. Collaboration can result in the development of new treatments and the market's growth for treating atrophic scars.

Restrains

• High treatment costs

Treatment for atrophic scars can be costly, particularly for complex procedures like laser therapy, surgical interventions, or combination therapies. For certain patients, especially those with inadequate insurance coverage or low financial resources, the high cost of treatment may make it difficult for them to receive it. A significant barrier to market expansion and a deterrent to people seeking scar therapy is affordability.

• Side effects and risk of treatment options

Treatment for atrophic scars has some risks, just like any medical operation. Depending on the mode of treatment, there may be possible adverse effects, including skin irritability, redness, ema edema, or even worsening of scarring in some circumstances. Individuals may be discouraged from seeking scar therapy due to worries about potential risks and adverse effects, which would restrict the market growth. 

Challenges

• Limited accessibility for seeking treatments

Advanced scar therapy solutions might not be as accessible in all geographic locations, especially in rural or impoverished areas. Urban areas or developed regions may have a higher concentration of the resources, technological technologies, and dermatologists needed for efficient scar therapy. The market's ability to grow and the accessibility of scar treatment services may be hampered by this.

• Lack of skilled personnel

In some areas or healthcare systems, the availability of zspecialized dermatologists or medical professionals skilled in scar treatment may be constrained. For best results, scar therapy frequently needs technical knowledge and skill. Access to high-quality scar therapy may differ depending on where there are more or fewer qualified medical professionals in a community , especially in rural or impoverished areas.

This atrophic scars treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biomarkers market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Recent Development

In April 2022, Lumens announced the launch of triLift, a facial stimulation device targeting three ageing elements – structure, contour, texture. The device affects the muscles, dermal layer and epidermal layer

Global Atrophic Scars Treatment Market Scope

The atrophic scars treatment market is segmented based on product type and distribution channel. The growth amongst these segments will help you ze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Laser
• Surface treatment
• Injectable
• Topical

Distribution Channel

• Clinics
• Pharmacies and drug stores
• Hospitals
• E-Commerce

Atrophic Scars Treatment Market Regional Analysis/Insights

The atrophic scars treatment market is analyzed, and market size insights and trends are provided by country, product type, and distribution channel as referenced above.

The countries covered in the atrophic scars treatment market report are the U.S., Canada and Mexico in North America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the atrophic scars treatment market due to the increase in the utilization of cosmetic treatments. Furthermore, the occurrence of major key players will further boost the growth of the atrophic scars treatment market in the region during the forecast period.

 Asia-Pacific is projected to observe significant growth in the atrophic scars treatment market due to the rise in cosmetic interventions. Moreover, the soaring demand for atrophic scar treatment is further anticipated to propel the growth of the atrophic scars treatment market in the region in the coming years.

The country section of the atrophic scars treatment market report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import-export analysis, price trend analysis, cost of raw materials, and downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The atrophic scars treatment market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the atrophic scars treatment market, impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the atrophic scars treatment market. The data is available for the historic period 2015-2020

Competitive Landscape and Atrophic Scars Treatment Market Share Analysis

The atrophic scars treatment market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the 'companies' focus on the atrophic scars treatment market.

Some of the major players operating in the atrophic scars treatment market are:

• Cynosure (U.S.)
• Merz Pharma (Germany)
• Perrigo Company plc (Ireland)
• CCA Industries Inc. (U.S.)
• Lumenis (U.S.)
• Candela Corporation (U.S.)
• Pacific World Corporation (U.S.)
• Bausch Health (Canada)
• Sonoba (U.K.)
• Otonomy Inc. (U.S.)
• Mölnlycke Health Care AB (Sweden)
• Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (China)
• Beijing Toplaser Technology Co. Ltd (China)
• Smith & Nephew plc (U.S.)
• Rejûvaskin (India)
• Bristol-Myers Squibb Company (U.S.)
• Torrent Pharmaceuticals Ltd (India)
• Novus Therapeutics, Inc. (U.S.)
• Pediapharm, Inc. (U.S.)
• Intas Pharmaceuticals Ltd. (India)

SKU-46289